nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—HTR7—coronary artery disease	0.184	0.665	CbGaD
Iloperidone—HTR2A—coronary artery disease	0.0928	0.335	CbGaD
Iloperidone—HTR1A—Penbutolol—coronary artery disease	0.0336	0.0826	CbGbCtD
Iloperidone—CYP3A7—Eplerenone—coronary artery disease	0.0216	0.0531	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0216	0.0531	CbGbCtD
Iloperidone—CYP3A5—Clopidogrel—coronary artery disease	0.0174	0.0429	CbGbCtD
Iloperidone—CYP3A5—Eplerenone—coronary artery disease	0.0162	0.0398	CbGbCtD
Iloperidone—CYP1A2—Gemfibrozil—coronary artery disease	0.015	0.0368	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.0139	0.0342	CbGbCtD
Iloperidone—CYP3A7—Simvastatin—coronary artery disease	0.0139	0.0342	CbGbCtD
Iloperidone—CYP3A7—Lovastatin—coronary artery disease	0.0136	0.0335	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.0136	0.0335	CbGbCtD
Iloperidone—CYP1A2—Clopidogrel—coronary artery disease	0.013	0.0319	CbGbCtD
Iloperidone—CYP3A7—Atorvastatin—coronary artery disease	0.0124	0.0305	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.0124	0.0305	CbGbCtD
Iloperidone—CYP3A5—Rosuvastatin—coronary artery disease	0.0112	0.0276	CbGbCtD
Iloperidone—CYP3A4—Ticagrelor—coronary artery disease	0.011	0.0271	CbGbCtD
Iloperidone—CYP3A5—Simvastatin—coronary artery disease	0.0105	0.0257	CbGbCtD
Iloperidone—CYP3A5—Lovastatin—coronary artery disease	0.0102	0.0251	CbGbCtD
Iloperidone—CYP3A5—Pravastatin—coronary artery disease	0.0102	0.0251	CbGbCtD
Iloperidone—CYP3A4—Fenofibrate—coronary artery disease	0.00982	0.0241	CbGbCtD
Iloperidone—CYP3A5—Atorvastatin—coronary artery disease	0.00932	0.0229	CbGbCtD
Iloperidone—CYP3A5—Losartan—coronary artery disease	0.00852	0.0209	CbGbCtD
Iloperidone—CYP2D6—Niacin—coronary artery disease	0.00811	0.0199	CbGbCtD
Iloperidone—CYP3A4—Gemfibrozil—coronary artery disease	0.00785	0.0193	CbGbCtD
Iloperidone—CYP2D6—Timolol—coronary artery disease	0.00754	0.0185	CbGbCtD
Iloperidone—CYP3A4—Clopidogrel—coronary artery disease	0.0068	0.0167	CbGbCtD
Iloperidone—CYP2D6—Captopril—coronary artery disease	0.00664	0.0163	CbGbCtD
Iloperidone—CYP2D6—Simvastatin—coronary artery disease	0.00641	0.0157	CbGbCtD
Iloperidone—CYP1A2—Losartan—coronary artery disease	0.00634	0.0156	CbGbCtD
Iloperidone—CYP3A4—Eplerenone—coronary artery disease	0.00633	0.0155	CbGbCtD
Iloperidone—CYP2D6—Pravastatin—coronary artery disease	0.00627	0.0154	CbGbCtD
Iloperidone—CYP2D6—Lovastatin—coronary artery disease	0.00627	0.0154	CbGbCtD
Iloperidone—CYP2D6—Atorvastatin—coronary artery disease	0.00571	0.014	CbGbCtD
Iloperidone—CYP3A4—Enalapril—coronary artery disease	0.00564	0.0138	CbGbCtD
Iloperidone—CYP3A4—Rosuvastatin—coronary artery disease	0.00438	0.0108	CbGbCtD
Iloperidone—CYP3A4—Ezetimibe—coronary artery disease	0.00438	0.0108	CbGbCtD
Iloperidone—CYP3A4—Simvastatin—coronary artery disease	0.00408	0.01	CbGbCtD
Iloperidone—CYP3A4—Pravastatin—coronary artery disease	0.00399	0.0098	CbGbCtD
Iloperidone—CYP3A4—Lovastatin—coronary artery disease	0.00399	0.0098	CbGbCtD
Iloperidone—CYP3A4—Atorvastatin—coronary artery disease	0.00363	0.00892	CbGbCtD
Iloperidone—CYP3A4—Losartan—coronary artery disease	0.00332	0.00816	CbGbCtD
Iloperidone—HTR7—pulmonary artery—coronary artery disease	0.00257	0.0726	CbGeAlD
Iloperidone—HTR7—sympathetic nervous system—coronary artery disease	0.0025	0.0706	CbGeAlD
Iloperidone—HTR2A—arteriole—coronary artery disease	0.00245	0.0691	CbGeAlD
Iloperidone—HTR7—vagus nerve—coronary artery disease	0.00242	0.0684	CbGeAlD
Iloperidone—HTR7—vein—coronary artery disease	0.00234	0.0661	CbGeAlD
Iloperidone—HTR7—autonomic nervous system—coronary artery disease	0.00168	0.0475	CbGeAlD
Iloperidone—HTR2A—pulmonary artery—coronary artery disease	0.0016	0.0453	CbGeAlD
Iloperidone—HTR2A—sympathetic nervous system—coronary artery disease	0.00156	0.044	CbGeAlD
Iloperidone—HTR2A—vagus nerve—coronary artery disease	0.00151	0.0427	CbGeAlD
Iloperidone—HTR2A—vein—coronary artery disease	0.00146	0.0412	CbGeAlD
Iloperidone—HTR1D—artery—coronary artery disease	0.0012	0.0338	CbGeAlD
Iloperidone—DRD4—heart—coronary artery disease	0.00112	0.0315	CbGeAlD
Iloperidone—HTR2A—autonomic nervous system—coronary artery disease	0.00105	0.0296	CbGeAlD
Iloperidone—HTR7—artery—coronary artery disease	0.000954	0.0269	CbGeAlD
Iloperidone—HTR7—endothelium—coronary artery disease	0.000805	0.0227	CbGeAlD
Iloperidone—SIGMAR1—cardiac ventricle—coronary artery disease	0.000626	0.0177	CbGeAlD
Iloperidone—HTR2A—artery—coronary artery disease	0.000595	0.0168	CbGeAlD
Iloperidone—SIGMAR1—myocardium—coronary artery disease	0.000589	0.0166	CbGeAlD
Iloperidone—Risperidone—HTR7—coronary artery disease	0.000539	0.252	CrCbGaD
Iloperidone—HTR2A—endothelium—coronary artery disease	0.000502	0.0142	CbGeAlD
Iloperidone—ADRA2C—cardiac ventricle—coronary artery disease	0.000492	0.0139	CbGeAlD
Iloperidone—ADRA2C—myocardium—coronary artery disease	0.000462	0.0131	CbGeAlD
Iloperidone—HTR1D—cardiovascular system—coronary artery disease	0.000416	0.0117	CbGeAlD
Iloperidone—SIGMAR1—heart—coronary artery disease	0.000411	0.0116	CbGeAlD
Iloperidone—Paliperidone—HTR2A—coronary artery disease	0.000364	0.17	CrCbGaD
Iloperidone—SIGMAR1—cardiac atrium—coronary artery disease	0.000352	0.00993	CbGeAlD
Iloperidone—HTR7—heart—coronary artery disease	0.000351	0.00992	CbGeAlD
Iloperidone—HTR1A—cardiovascular system—coronary artery disease	0.000347	0.00979	CbGeAlD
Iloperidone—Cisapride—CYP2C19—coronary artery disease	0.00034	0.159	CrCbGaD
Iloperidone—ADRA1A—heart—coronary artery disease	0.000339	0.00956	CbGeAlD
Iloperidone—HTR7—cardiovascular system—coronary artery disease	0.000331	0.00936	CbGeAlD
Iloperidone—ADRA2C—heart—coronary artery disease	0.000323	0.00911	CbGeAlD
Iloperidone—ADRA1A—cardiovascular system—coronary artery disease	0.00032	0.00903	CbGeAlD
Iloperidone—SIGMAR1—blood—coronary artery disease	0.000307	0.00866	CbGeAlD
Iloperidone—ADRA2C—cardiac atrium—coronary artery disease	0.000276	0.00779	CbGeAlD
Iloperidone—Cisapride—HTR2A—coronary artery disease	0.000275	0.129	CrCbGaD
Iloperidone—Risperidone—HTR2A—coronary artery disease	0.000271	0.127	CrCbGaD
Iloperidone—HTR7—blood—coronary artery disease	0.000262	0.0074	CbGeAlD
Iloperidone—ADRA2A—heart—coronary artery disease	0.000258	0.00727	CbGeAlD
Iloperidone—ADRA1A—blood—coronary artery disease	0.000253	0.00714	CbGeAlD
Iloperidone—ADRA2C—blood—coronary artery disease	0.000241	0.0068	CbGeAlD
Iloperidone—CYP2E1—cardiovascular system—coronary artery disease	0.000238	0.00671	CbGeAlD
Iloperidone—Gefitinib—CYP2C19—coronary artery disease	0.000226	0.106	CrCbGaD
Iloperidone—ADRA2A—cardiac atrium—coronary artery disease	0.00022	0.00622	CbGeAlD
Iloperidone—HTR2A—heart—coronary artery disease	0.000219	0.00618	CbGeAlD
Iloperidone—CYP1A2—blood—coronary artery disease	0.000209	0.0059	CbGeAlD
Iloperidone—HTR2A—cardiovascular system—coronary artery disease	0.000207	0.00583	CbGeAlD
Iloperidone—CYP3A5—blood—coronary artery disease	0.000202	0.00569	CbGeAlD
Iloperidone—ADRA2A—blood—coronary artery disease	0.000192	0.00543	CbGeAlD
Iloperidone—CYP2E1—blood—coronary artery disease	0.000188	0.00531	CbGeAlD
Iloperidone—HTR2A—blood—coronary artery disease	0.000163	0.00461	CbGeAlD
Iloperidone—CYP3A4—blood—coronary artery disease	0.000151	0.00427	CbGeAlD
Iloperidone—CYP2D6—blood—coronary artery disease	0.000149	0.0042	CbGeAlD
Iloperidone—Gefitinib—ALB—coronary artery disease	0.000125	0.0585	CrCbGaD
Iloperidone—Dry mouth—Losartan—coronary artery disease	8.84e-05	0.000553	CcSEcCtD
Iloperidone—Somnolence—Enalapril—coronary artery disease	8.82e-05	0.000551	CcSEcCtD
Iloperidone—Nervous system disorder—Furosemide—coronary artery disease	8.81e-05	0.000551	CcSEcCtD
Iloperidone—Feeling abnormal—Olmesartan—coronary artery disease	8.79e-05	0.000549	CcSEcCtD
Iloperidone—Paraesthesia—Telmisartan—coronary artery disease	8.79e-05	0.000549	CcSEcCtD
Iloperidone—Rash—Acetylsalicylic acid—coronary artery disease	8.77e-05	0.000548	CcSEcCtD
Iloperidone—Asthenia—Clopidogrel—coronary artery disease	8.76e-05	0.000548	CcSEcCtD
Iloperidone—Dermatitis—Acetylsalicylic acid—coronary artery disease	8.76e-05	0.000548	CcSEcCtD
Iloperidone—Muscle spasms—Ramipril—coronary artery disease	8.75e-05	0.000547	CcSEcCtD
Iloperidone—Confusional state—Losartan—coronary artery disease	8.74e-05	0.000546	CcSEcCtD
Iloperidone—Dyspnoea—Telmisartan—coronary artery disease	8.72e-05	0.000545	CcSEcCtD
Iloperidone—Asthenia—Lovastatin—coronary artery disease	8.7e-05	0.000544	CcSEcCtD
Iloperidone—Somnolence—Telmisartan—coronary artery disease	8.7e-05	0.000544	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Captopril—coronary artery disease	8.67e-05	0.000542	CcSEcCtD
Iloperidone—Oedema—Losartan—coronary artery disease	8.66e-05	0.000542	CcSEcCtD
Iloperidone—Hypotension—Perindopril—coronary artery disease	8.63e-05	0.00054	CcSEcCtD
Iloperidone—Infection—Losartan—coronary artery disease	8.61e-05	0.000538	CcSEcCtD
Iloperidone—Angiopathy—Lisinopril—coronary artery disease	8.6e-05	0.000538	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Trandolapril—coronary artery disease	8.6e-05	0.000538	CcSEcCtD
Iloperidone—Fatigue—Trandolapril—coronary artery disease	8.59e-05	0.000537	CcSEcCtD
Iloperidone—Fatigue—Enalapril—coronary artery disease	8.55e-05	0.000535	CcSEcCtD
Iloperidone—Mediastinal disorder—Lisinopril—coronary artery disease	8.55e-05	0.000534	CcSEcCtD
Iloperidone—Paraesthesia—Captopril—coronary artery disease	8.54e-05	0.000534	CcSEcCtD
Iloperidone—Asthenia—Ezetimibe—coronary artery disease	8.53e-05	0.000534	CcSEcCtD
Iloperidone—Tremor—Ramipril—coronary artery disease	8.53e-05	0.000533	CcSEcCtD
Iloperidone—Nausea—Rosuvastatin—coronary artery disease	8.5e-05	0.000532	CcSEcCtD
Iloperidone—Diarrhoea—Fenofibrate—coronary artery disease	8.5e-05	0.000531	CcSEcCtD
Iloperidone—Nervous system disorder—Losartan—coronary artery disease	8.5e-05	0.000531	CcSEcCtD
Iloperidone—Dyspnoea—Captopril—coronary artery disease	8.48e-05	0.00053	CcSEcCtD
Iloperidone—Arrhythmia—Lisinopril—coronary artery disease	8.47e-05	0.00053	CcSEcCtD
Iloperidone—Somnolence—Captopril—coronary artery disease	8.46e-05	0.000529	CcSEcCtD
Iloperidone—Tachycardia—Losartan—coronary artery disease	8.46e-05	0.000529	CcSEcCtD
Iloperidone—Feeling abnormal—Pravastatin—coronary artery disease	8.45e-05	0.000528	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Telmisartan—coronary artery disease	8.45e-05	0.000528	CcSEcCtD
Iloperidone—Fatigue—Telmisartan—coronary artery disease	8.44e-05	0.000527	CcSEcCtD
Iloperidone—Body temperature increased—Olmesartan—coronary artery disease	8.43e-05	0.000527	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Perindopril—coronary artery disease	8.42e-05	0.000526	CcSEcCtD
Iloperidone—Hypotension—Furosemide—coronary artery disease	8.39e-05	0.000525	CcSEcCtD
Iloperidone—Vision blurred—Timolol—coronary artery disease	8.39e-05	0.000524	CcSEcCtD
Iloperidone—Agitation—Ramipril—coronary artery disease	8.37e-05	0.000523	CcSEcCtD
Iloperidone—Diarrhoea—Clopidogrel—coronary artery disease	8.35e-05	0.000522	CcSEcCtD
Iloperidone—Asthenia—Eplerenone—coronary artery disease	8.35e-05	0.000522	CcSEcCtD
Iloperidone—Mental disorder—Lisinopril—coronary artery disease	8.31e-05	0.00052	CcSEcCtD
Iloperidone—Diarrhoea—Lovastatin—coronary artery disease	8.3e-05	0.000519	CcSEcCtD
Iloperidone—Paraesthesia—Perindopril—coronary artery disease	8.29e-05	0.000519	CcSEcCtD
Iloperidone—Nausea—Acetylsalicylic acid—coronary artery disease	8.26e-05	0.000516	CcSEcCtD
Iloperidone—Malnutrition—Lisinopril—coronary artery disease	8.26e-05	0.000516	CcSEcCtD
Iloperidone—Dyspnoea—Perindopril—coronary artery disease	8.24e-05	0.000515	CcSEcCtD
Iloperidone—Body temperature increased—Niacin—coronary artery disease	8.23e-05	0.000515	CcSEcCtD
Iloperidone—Dizziness—Fenofibrate—coronary artery disease	8.21e-05	0.000514	CcSEcCtD
Iloperidone—Somnolence—Perindopril—coronary artery disease	8.21e-05	0.000514	CcSEcCtD
Iloperidone—Feeling abnormal—Trandolapril—coronary artery disease	8.21e-05	0.000513	CcSEcCtD
Iloperidone—Fatigue—Captopril—coronary artery disease	8.2e-05	0.000513	CcSEcCtD
Iloperidone—Vertigo—Ramipril—coronary artery disease	8.18e-05	0.000511	CcSEcCtD
Iloperidone—Feeling abnormal—Enalapril—coronary artery disease	8.17e-05	0.000511	CcSEcCtD
Iloperidone—Leukopenia—Ramipril—coronary artery disease	8.15e-05	0.00051	CcSEcCtD
Iloperidone—Asthenia—Simvastatin—coronary artery disease	8.14e-05	0.000509	CcSEcCtD
Iloperidone—Diarrhoea—Ezetimibe—coronary artery disease	8.14e-05	0.000509	CcSEcCtD
Iloperidone—Body temperature increased—Pravastatin—coronary artery disease	8.11e-05	0.000507	CcSEcCtD
Iloperidone—Hypotension—Losartan—coronary artery disease	8.1e-05	0.000506	CcSEcCtD
Iloperidone—Dizziness—Clopidogrel—coronary artery disease	8.07e-05	0.000505	CcSEcCtD
Iloperidone—Paraesthesia—Furosemide—coronary artery disease	8.06e-05	0.000504	CcSEcCtD
Iloperidone—Feeling abnormal—Telmisartan—coronary artery disease	8.06e-05	0.000504	CcSEcCtD
Iloperidone—Palpitations—Ramipril—coronary artery disease	8.04e-05	0.000503	CcSEcCtD
Iloperidone—Dizziness—Lovastatin—coronary artery disease	8.02e-05	0.000501	CcSEcCtD
Iloperidone—Vertigo—Timolol—coronary artery disease	8e-05	0.0005	CcSEcCtD
Iloperidone—Somnolence—Furosemide—coronary artery disease	7.98e-05	0.000499	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Perindopril—coronary artery disease	7.97e-05	0.000499	CcSEcCtD
Iloperidone—Diarrhoea—Eplerenone—coronary artery disease	7.97e-05	0.000498	CcSEcCtD
Iloperidone—Fatigue—Perindopril—coronary artery disease	7.96e-05	0.000498	CcSEcCtD
Iloperidone—Muscle spasms—Lisinopril—coronary artery disease	7.94e-05	0.000496	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Losartan—coronary artery disease	7.89e-05	0.000494	CcSEcCtD
Iloperidone—Body temperature increased—Trandolapril—coronary artery disease	7.87e-05	0.000492	CcSEcCtD
Iloperidone—Dizziness—Ezetimibe—coronary artery disease	7.87e-05	0.000492	CcSEcCtD
Iloperidone—Palpitations—Timolol—coronary artery disease	7.86e-05	0.000492	CcSEcCtD
Iloperidone—Body temperature increased—Enalapril—coronary artery disease	7.84e-05	0.00049	CcSEcCtD
Iloperidone—Feeling abnormal—Captopril—coronary artery disease	7.84e-05	0.00049	CcSEcCtD
Iloperidone—Rash—Fenofibrate—coronary artery disease	7.83e-05	0.00049	CcSEcCtD
Iloperidone—Dermatitis—Fenofibrate—coronary artery disease	7.82e-05	0.000489	CcSEcCtD
Iloperidone—Vision blurred—Lisinopril—coronary artery disease	7.78e-05	0.000487	CcSEcCtD
Iloperidone—Paraesthesia—Losartan—coronary artery disease	7.78e-05	0.000486	CcSEcCtD
Iloperidone—Diarrhoea—Simvastatin—coronary artery disease	7.76e-05	0.000485	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Furosemide—coronary artery disease	7.75e-05	0.000485	CcSEcCtD
Iloperidone—Myalgia—Ramipril—coronary artery disease	7.75e-05	0.000485	CcSEcCtD
Iloperidone—Arthralgia—Ramipril—coronary artery disease	7.75e-05	0.000485	CcSEcCtD
Iloperidone—Fatigue—Furosemide—coronary artery disease	7.74e-05	0.000484	CcSEcCtD
Iloperidone—Tremor—Lisinopril—coronary artery disease	7.73e-05	0.000484	CcSEcCtD
Iloperidone—Body temperature increased—Telmisartan—coronary artery disease	7.73e-05	0.000484	CcSEcCtD
Iloperidone—Dyspnoea—Losartan—coronary artery disease	7.72e-05	0.000483	CcSEcCtD
Iloperidone—Somnolence—Losartan—coronary artery disease	7.7e-05	0.000482	CcSEcCtD
Iloperidone—Dizziness—Eplerenone—coronary artery disease	7.7e-05	0.000481	CcSEcCtD
Iloperidone—Rash—Clopidogrel—coronary artery disease	7.7e-05	0.000481	CcSEcCtD
Iloperidone—Dermatitis—Clopidogrel—coronary artery disease	7.69e-05	0.000481	CcSEcCtD
Iloperidone—Asthenia—Valsartan—coronary artery disease	7.69e-05	0.000481	CcSEcCtD
Iloperidone—Asthenia—Olmesartan—coronary artery disease	7.65e-05	0.000478	CcSEcCtD
Iloperidone—Rash—Lovastatin—coronary artery disease	7.65e-05	0.000478	CcSEcCtD
Iloperidone—Dermatitis—Lovastatin—coronary artery disease	7.64e-05	0.000478	CcSEcCtD
Iloperidone—Anaemia—Lisinopril—coronary artery disease	7.63e-05	0.000477	CcSEcCtD
Iloperidone—Feeling abnormal—Perindopril—coronary artery disease	7.61e-05	0.000476	CcSEcCtD
Iloperidone—Dry mouth—Ramipril—coronary artery disease	7.58e-05	0.000474	CcSEcCtD
Iloperidone—Myalgia—Timolol—coronary artery disease	7.58e-05	0.000474	CcSEcCtD
Iloperidone—Arthralgia—Timolol—coronary artery disease	7.58e-05	0.000474	CcSEcCtD
Iloperidone—Body temperature increased—Captopril—coronary artery disease	7.52e-05	0.00047	CcSEcCtD
Iloperidone—Dizziness—Simvastatin—coronary artery disease	7.5e-05	0.000469	CcSEcCtD
Iloperidone—Rash—Ezetimibe—coronary artery disease	7.5e-05	0.000469	CcSEcCtD
Iloperidone—Dermatitis—Ezetimibe—coronary artery disease	7.49e-05	0.000469	CcSEcCtD
Iloperidone—Confusional state—Ramipril—coronary artery disease	7.49e-05	0.000468	CcSEcCtD
Iloperidone—Asthenia—Niacin—coronary artery disease	7.47e-05	0.000467	CcSEcCtD
Iloperidone—Fatigue—Losartan—coronary artery disease	7.47e-05	0.000467	CcSEcCtD
Iloperidone—Oedema—Ramipril—coronary artery disease	7.43e-05	0.000465	CcSEcCtD
Iloperidone—Vertigo—Lisinopril—coronary artery disease	7.42e-05	0.000464	CcSEcCtD
Iloperidone—Dry mouth—Timolol—coronary artery disease	7.41e-05	0.000463	CcSEcCtD
Iloperidone—Feeling abnormal—Furosemide—coronary artery disease	7.4e-05	0.000463	CcSEcCtD
Iloperidone—Leukopenia—Lisinopril—coronary artery disease	7.39e-05	0.000462	CcSEcCtD
Iloperidone—Nausea—Fenofibrate—coronary artery disease	7.38e-05	0.000461	CcSEcCtD
Iloperidone—Asthenia—Pravastatin—coronary artery disease	7.36e-05	0.00046	CcSEcCtD
Iloperidone—Rash—Eplerenone—coronary artery disease	7.34e-05	0.000459	CcSEcCtD
Iloperidone—Dermatitis—Eplerenone—coronary artery disease	7.33e-05	0.000459	CcSEcCtD
Iloperidone—Diarrhoea—Valsartan—coronary artery disease	7.33e-05	0.000458	CcSEcCtD
Iloperidone—Confusional state—Timolol—coronary artery disease	7.32e-05	0.000458	CcSEcCtD
Iloperidone—Body temperature increased—Perindopril—coronary artery disease	7.3e-05	0.000457	CcSEcCtD
Iloperidone—Palpitations—Lisinopril—coronary artery disease	7.3e-05	0.000456	CcSEcCtD
Iloperidone—Diarrhoea—Olmesartan—coronary artery disease	7.29e-05	0.000456	CcSEcCtD
Iloperidone—Nervous system disorder—Ramipril—coronary artery disease	7.29e-05	0.000456	CcSEcCtD
Iloperidone—Oedema—Timolol—coronary artery disease	7.26e-05	0.000454	CcSEcCtD
Iloperidone—Nausea—Clopidogrel—coronary artery disease	7.25e-05	0.000453	CcSEcCtD
Iloperidone—Tachycardia—Ramipril—coronary artery disease	7.25e-05	0.000453	CcSEcCtD
Iloperidone—Infection—Timolol—coronary artery disease	7.22e-05	0.000451	CcSEcCtD
Iloperidone—Nausea—Lovastatin—coronary artery disease	7.2e-05	0.00045	CcSEcCtD
Iloperidone—Rash—Simvastatin—coronary artery disease	7.15e-05	0.000447	CcSEcCtD
Iloperidone—Dermatitis—Simvastatin—coronary artery disease	7.15e-05	0.000447	CcSEcCtD
Iloperidone—Asthenia—Trandolapril—coronary artery disease	7.15e-05	0.000447	CcSEcCtD
Iloperidone—Feeling abnormal—Losartan—coronary artery disease	7.14e-05	0.000446	CcSEcCtD
Iloperidone—Diarrhoea—Niacin—coronary artery disease	7.13e-05	0.000446	CcSEcCtD
Iloperidone—Nervous system disorder—Timolol—coronary artery disease	7.12e-05	0.000445	CcSEcCtD
Iloperidone—Asthenia—Enalapril—coronary artery disease	7.12e-05	0.000445	CcSEcCtD
Iloperidone—Body temperature increased—Furosemide—coronary artery disease	7.1e-05	0.000444	CcSEcCtD
Iloperidone—Dizziness—Valsartan—coronary artery disease	7.08e-05	0.000443	CcSEcCtD
Iloperidone—Nausea—Ezetimibe—coronary artery disease	7.07e-05	0.000442	CcSEcCtD
Iloperidone—Dizziness—Olmesartan—coronary artery disease	7.05e-05	0.000441	CcSEcCtD
Iloperidone—Myalgia—Lisinopril—coronary artery disease	7.03e-05	0.000439	CcSEcCtD
Iloperidone—Arthralgia—Lisinopril—coronary artery disease	7.03e-05	0.000439	CcSEcCtD
Iloperidone—Asthenia—Telmisartan—coronary artery disease	7.02e-05	0.000439	CcSEcCtD
Iloperidone—Diarrhoea—Pravastatin—coronary artery disease	7.02e-05	0.000439	CcSEcCtD
Iloperidone—Hypotension—Ramipril—coronary artery disease	6.94e-05	0.000434	CcSEcCtD
Iloperidone—Nausea—Eplerenone—coronary artery disease	6.92e-05	0.000432	CcSEcCtD
Iloperidone—Dizziness—Niacin—coronary artery disease	6.89e-05	0.000431	CcSEcCtD
Iloperidone—Dry mouth—Lisinopril—coronary artery disease	6.87e-05	0.00043	CcSEcCtD
Iloperidone—Body temperature increased—Losartan—coronary artery disease	6.85e-05	0.000428	CcSEcCtD
Iloperidone—Asthenia—Captopril—coronary artery disease	6.83e-05	0.000427	CcSEcCtD
Iloperidone—Diarrhoea—Trandolapril—coronary artery disease	6.81e-05	0.000426	CcSEcCtD
Iloperidone—Confusional state—Lisinopril—coronary artery disease	6.79e-05	0.000425	CcSEcCtD
Iloperidone—Diarrhoea—Enalapril—coronary artery disease	6.79e-05	0.000424	CcSEcCtD
Iloperidone—Hypotension—Timolol—coronary artery disease	6.79e-05	0.000424	CcSEcCtD
Iloperidone—Dizziness—Pravastatin—coronary artery disease	6.78e-05	0.000424	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Ramipril—coronary artery disease	6.77e-05	0.000423	CcSEcCtD
Iloperidone—Rash—Valsartan—coronary artery disease	6.75e-05	0.000422	CcSEcCtD
Iloperidone—Dermatitis—Valsartan—coronary artery disease	6.75e-05	0.000422	CcSEcCtD
Iloperidone—Nausea—Simvastatin—coronary artery disease	6.74e-05	0.000421	CcSEcCtD
Iloperidone—Oedema—Lisinopril—coronary artery disease	6.74e-05	0.000421	CcSEcCtD
Iloperidone—Rash—Olmesartan—coronary artery disease	6.72e-05	0.00042	CcSEcCtD
Iloperidone—Dermatitis—Olmesartan—coronary artery disease	6.72e-05	0.00042	CcSEcCtD
Iloperidone—Diarrhoea—Telmisartan—coronary artery disease	6.69e-05	0.000419	CcSEcCtD
Iloperidone—Infection—Lisinopril—coronary artery disease	6.69e-05	0.000419	CcSEcCtD
Iloperidone—Paraesthesia—Ramipril—coronary artery disease	6.67e-05	0.000417	CcSEcCtD
Iloperidone—Asthenia—Perindopril—coronary artery disease	6.63e-05	0.000414	CcSEcCtD
Iloperidone—Dyspnoea—Ramipril—coronary artery disease	6.62e-05	0.000414	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Timolol—coronary artery disease	6.62e-05	0.000414	CcSEcCtD
Iloperidone—Somnolence—Ramipril—coronary artery disease	6.6e-05	0.000413	CcSEcCtD
Iloperidone—Dizziness—Trandolapril—coronary artery disease	6.59e-05	0.000412	CcSEcCtD
Iloperidone—Tachycardia—Lisinopril—coronary artery disease	6.58e-05	0.000411	CcSEcCtD
Iloperidone—Rash—Niacin—coronary artery disease	6.57e-05	0.000411	CcSEcCtD
Iloperidone—Dermatitis—Niacin—coronary artery disease	6.56e-05	0.00041	CcSEcCtD
Iloperidone—Dizziness—Enalapril—coronary artery disease	6.56e-05	0.00041	CcSEcCtD
Iloperidone—Paraesthesia—Timolol—coronary artery disease	6.52e-05	0.000408	CcSEcCtD
Iloperidone—Diarrhoea—Captopril—coronary artery disease	6.51e-05	0.000407	CcSEcCtD
Iloperidone—Dyspnoea—Timolol—coronary artery disease	6.48e-05	0.000405	CcSEcCtD
Iloperidone—Dizziness—Telmisartan—coronary artery disease	6.47e-05	0.000405	CcSEcCtD
Iloperidone—Rash—Pravastatin—coronary artery disease	6.47e-05	0.000404	CcSEcCtD
Iloperidone—Dermatitis—Pravastatin—coronary artery disease	6.46e-05	0.000404	CcSEcCtD
Iloperidone—Somnolence—Timolol—coronary artery disease	6.46e-05	0.000404	CcSEcCtD
Iloperidone—Asthenia—Furosemide—coronary artery disease	6.44e-05	0.000403	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Ramipril—coronary artery disease	6.41e-05	0.000401	CcSEcCtD
Iloperidone—Fatigue—Ramipril—coronary artery disease	6.41e-05	0.000401	CcSEcCtD
Iloperidone—Nausea—Valsartan—coronary artery disease	6.36e-05	0.000398	CcSEcCtD
Iloperidone—Nausea—Olmesartan—coronary artery disease	6.33e-05	0.000396	CcSEcCtD
Iloperidone—Diarrhoea—Perindopril—coronary artery disease	6.32e-05	0.000395	CcSEcCtD
Iloperidone—Hypotension—Lisinopril—coronary artery disease	6.3e-05	0.000394	CcSEcCtD
Iloperidone—Dizziness—Captopril—coronary artery disease	6.29e-05	0.000393	CcSEcCtD
Iloperidone—Rash—Trandolapril—coronary artery disease	6.28e-05	0.000393	CcSEcCtD
Iloperidone—Dermatitis—Trandolapril—coronary artery disease	6.27e-05	0.000392	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Timolol—coronary artery disease	6.27e-05	0.000392	CcSEcCtD
Iloperidone—Fatigue—Timolol—coronary artery disease	6.26e-05	0.000392	CcSEcCtD
Iloperidone—Rash—Enalapril—coronary artery disease	6.25e-05	0.000391	CcSEcCtD
Iloperidone—Dermatitis—Enalapril—coronary artery disease	6.25e-05	0.000391	CcSEcCtD
Iloperidone—Asthenia—Losartan—coronary artery disease	6.22e-05	0.000389	CcSEcCtD
Iloperidone—Nausea—Niacin—coronary artery disease	6.19e-05	0.000387	CcSEcCtD
Iloperidone—Rash—Telmisartan—coronary artery disease	6.17e-05	0.000386	CcSEcCtD
Iloperidone—Dermatitis—Telmisartan—coronary artery disease	6.16e-05	0.000385	CcSEcCtD
Iloperidone—Diarrhoea—Furosemide—coronary artery disease	6.14e-05	0.000384	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Lisinopril—coronary artery disease	6.14e-05	0.000384	CcSEcCtD
Iloperidone—Feeling abnormal—Ramipril—coronary artery disease	6.12e-05	0.000383	CcSEcCtD
Iloperidone—Dizziness—Perindopril—coronary artery disease	6.11e-05	0.000382	CcSEcCtD
Iloperidone—Nausea—Pravastatin—coronary artery disease	6.09e-05	0.000381	CcSEcCtD
Iloperidone—Paraesthesia—Lisinopril—coronary artery disease	6.05e-05	0.000378	CcSEcCtD
Iloperidone—Dyspnoea—Lisinopril—coronary artery disease	6.01e-05	0.000376	CcSEcCtD
Iloperidone—Rash—Captopril—coronary artery disease	6e-05	0.000375	CcSEcCtD
Iloperidone—Dermatitis—Captopril—coronary artery disease	5.99e-05	0.000375	CcSEcCtD
Iloperidone—Somnolence—Lisinopril—coronary artery disease	5.99e-05	0.000375	CcSEcCtD
Iloperidone—Feeling abnormal—Timolol—coronary artery disease	5.98e-05	0.000374	CcSEcCtD
Iloperidone—Dizziness—Furosemide—coronary artery disease	5.94e-05	0.000371	CcSEcCtD
Iloperidone—Diarrhoea—Losartan—coronary artery disease	5.93e-05	0.000371	CcSEcCtD
Iloperidone—Nausea—Trandolapril—coronary artery disease	5.92e-05	0.00037	CcSEcCtD
Iloperidone—Nausea—Enalapril—coronary artery disease	5.89e-05	0.000368	CcSEcCtD
Iloperidone—Body temperature increased—Ramipril—coronary artery disease	5.87e-05	0.000367	CcSEcCtD
Iloperidone—Rash—Perindopril—coronary artery disease	5.82e-05	0.000364	CcSEcCtD
Iloperidone—Dermatitis—Perindopril—coronary artery disease	5.82e-05	0.000364	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Lisinopril—coronary artery disease	5.82e-05	0.000364	CcSEcCtD
Iloperidone—Nausea—Telmisartan—coronary artery disease	5.81e-05	0.000363	CcSEcCtD
Iloperidone—Fatigue—Lisinopril—coronary artery disease	5.81e-05	0.000363	CcSEcCtD
Iloperidone—Body temperature increased—Timolol—coronary artery disease	5.74e-05	0.000359	CcSEcCtD
Iloperidone—Dizziness—Losartan—coronary artery disease	5.73e-05	0.000358	CcSEcCtD
Iloperidone—Rash—Furosemide—coronary artery disease	5.66e-05	0.000354	CcSEcCtD
Iloperidone—Dermatitis—Furosemide—coronary artery disease	5.66e-05	0.000354	CcSEcCtD
Iloperidone—Nausea—Captopril—coronary artery disease	5.65e-05	0.000353	CcSEcCtD
Iloperidone—Feeling abnormal—Lisinopril—coronary artery disease	5.55e-05	0.000347	CcSEcCtD
Iloperidone—Nausea—Perindopril—coronary artery disease	5.49e-05	0.000343	CcSEcCtD
Iloperidone—Rash—Losartan—coronary artery disease	5.46e-05	0.000342	CcSEcCtD
Iloperidone—Dermatitis—Losartan—coronary artery disease	5.46e-05	0.000341	CcSEcCtD
Iloperidone—Nausea—Furosemide—coronary artery disease	5.33e-05	0.000334	CcSEcCtD
Iloperidone—Asthenia—Ramipril—coronary artery disease	5.33e-05	0.000333	CcSEcCtD
Iloperidone—Body temperature increased—Lisinopril—coronary artery disease	5.33e-05	0.000333	CcSEcCtD
Iloperidone—Asthenia—Timolol—coronary artery disease	5.21e-05	0.000326	CcSEcCtD
Iloperidone—Nausea—Losartan—coronary artery disease	5.15e-05	0.000322	CcSEcCtD
Iloperidone—Diarrhoea—Ramipril—coronary artery disease	5.08e-05	0.000318	CcSEcCtD
Iloperidone—Diarrhoea—Timolol—coronary artery disease	4.97e-05	0.000311	CcSEcCtD
Iloperidone—Dizziness—Ramipril—coronary artery disease	4.91e-05	0.000307	CcSEcCtD
Iloperidone—Asthenia—Lisinopril—coronary artery disease	4.83e-05	0.000302	CcSEcCtD
Iloperidone—Dizziness—Timolol—coronary artery disease	4.8e-05	0.0003	CcSEcCtD
Iloperidone—Rash—Ramipril—coronary artery disease	4.68e-05	0.000293	CcSEcCtD
Iloperidone—Dermatitis—Ramipril—coronary artery disease	4.68e-05	0.000293	CcSEcCtD
Iloperidone—Diarrhoea—Lisinopril—coronary artery disease	4.61e-05	0.000288	CcSEcCtD
Iloperidone—Rash—Timolol—coronary artery disease	4.58e-05	0.000286	CcSEcCtD
Iloperidone—Dermatitis—Timolol—coronary artery disease	4.58e-05	0.000286	CcSEcCtD
Iloperidone—Dizziness—Lisinopril—coronary artery disease	4.46e-05	0.000279	CcSEcCtD
Iloperidone—Nausea—Ramipril—coronary artery disease	4.41e-05	0.000276	CcSEcCtD
Iloperidone—Nausea—Timolol—coronary artery disease	4.31e-05	0.00027	CcSEcCtD
Iloperidone—Rash—Lisinopril—coronary artery disease	4.25e-05	0.000266	CcSEcCtD
Iloperidone—Dermatitis—Lisinopril—coronary artery disease	4.24e-05	0.000265	CcSEcCtD
Iloperidone—Nausea—Lisinopril—coronary artery disease	4e-05	0.00025	CcSEcCtD
Iloperidone—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.49e-06	1.26e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.49e-06	1.26e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GOT2—coronary artery disease	1.49e-06	1.26e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	1.48e-06	1.25e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.48e-06	1.25e-05	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.48e-06	1.25e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—AKT1—coronary artery disease	1.48e-06	1.25e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	1.48e-06	1.25e-05	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.48e-06	1.25e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.47e-06	1.25e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	1.47e-06	1.25e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—ALB—coronary artery disease	1.47e-06	1.25e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	1.47e-06	1.24e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—POMC—coronary artery disease	1.47e-06	1.24e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—ALB—coronary artery disease	1.47e-06	1.24e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—TGFB1—coronary artery disease	1.46e-06	1.23e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—AKT1—coronary artery disease	1.46e-06	1.23e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—TGFB1—coronary artery disease	1.46e-06	1.23e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CAT—coronary artery disease	1.45e-06	1.23e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—FGF2—coronary artery disease	1.45e-06	1.23e-05	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.45e-06	1.22e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	1.45e-06	1.22e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—TGFB1—coronary artery disease	1.45e-06	1.22e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	1.45e-06	1.22e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	1.44e-06	1.22e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	1.44e-06	1.22e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	1.43e-06	1.21e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.43e-06	1.21e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—NOS3—coronary artery disease	1.43e-06	1.21e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—MAPK1—coronary artery disease	1.43e-06	1.21e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—FGF2—coronary artery disease	1.43e-06	1.21e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—MAPK1—coronary artery disease	1.43e-06	1.21e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—FGF2—coronary artery disease	1.43e-06	1.21e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—MAPK1—coronary artery disease	1.42e-06	1.2e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	1.41e-06	1.2e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—APOB—coronary artery disease	1.41e-06	1.19e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—NOS3—coronary artery disease	1.41e-06	1.19e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—NOS3—coronary artery disease	1.41e-06	1.19e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	1.41e-06	1.19e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—NOS3—coronary artery disease	1.41e-06	1.19e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—NOS3—coronary artery disease	1.41e-06	1.19e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—PTGS2—coronary artery disease	1.4e-06	1.19e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	1.4e-06	1.18e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	1.4e-06	1.18e-05	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	1.4e-06	1.18e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TGFB1—coronary artery disease	1.39e-06	1.18e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—JAK2—coronary artery disease	1.39e-06	1.18e-05	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	1.39e-06	1.18e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CASP3—coronary artery disease	1.39e-06	1.17e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	1.38e-06	1.17e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CASP3—coronary artery disease	1.38e-06	1.17e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—IL6—coronary artery disease	1.38e-06	1.16e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.37e-06	1.16e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—JAK2—coronary artery disease	1.37e-06	1.16e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—IL6—coronary artery disease	1.37e-06	1.16e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.37e-06	1.16e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—JAK2—coronary artery disease	1.37e-06	1.16e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—VEGFA—coronary artery disease	1.37e-06	1.16e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—MAPK1—coronary artery disease	1.37e-06	1.16e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	1.36e-06	1.15e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—AGT—coronary artery disease	1.36e-06	1.15e-05	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	1.35e-06	1.14e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—VEGFA—coronary artery disease	1.35e-06	1.14e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CCND1—coronary artery disease	1.35e-06	1.14e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—LPL—coronary artery disease	1.35e-06	1.14e-05	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.35e-06	1.14e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	1.34e-06	1.14e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.34e-06	1.14e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CCND1—coronary artery disease	1.34e-06	1.13e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	1.34e-06	1.13e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	1.34e-06	1.13e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	1.34e-06	1.13e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—APOE—coronary artery disease	1.33e-06	1.13e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	1.33e-06	1.13e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.33e-06	1.12e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—APOA1—coronary artery disease	1.32e-06	1.12e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GPX1—coronary artery disease	1.32e-06	1.11e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	1.31e-06	1.11e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MMP9—coronary artery disease	1.31e-06	1.11e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	1.3e-06	1.1e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MMP9—coronary artery disease	1.3e-06	1.1e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	1.3e-06	1.1e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—PTGS2—coronary artery disease	1.29e-06	1.09e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—PTGS2—coronary artery disease	1.29e-06	1.09e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GGT1—coronary artery disease	1.28e-06	1.09e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GOT1—coronary artery disease	1.28e-06	1.09e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	1.28e-06	1.09e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CD36—coronary artery disease	1.28e-06	1.08e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CXCL8—coronary artery disease	1.27e-06	1.08e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	1.27e-06	1.07e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	1.27e-06	1.07e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.26e-06	1.07e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	1.26e-06	1.07e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TGFB1—coronary artery disease	1.25e-06	1.06e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	1.25e-06	1.06e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CXCL8—coronary artery disease	1.25e-06	1.06e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	1.25e-06	1.05e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—PIK3CA—coronary artery disease	1.24e-06	1.05e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—PIK3CA—coronary artery disease	1.24e-06	1.05e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TGFB1—coronary artery disease	1.24e-06	1.05e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—PIK3CA—coronary artery disease	1.23e-06	1.04e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—MAPK1—coronary artery disease	1.23e-06	1.04e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	1.23e-06	1.04e-05	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	1.23e-06	1.04e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	1.22e-06	1.04e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.22e-06	1.03e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CASP3—coronary artery disease	1.22e-06	1.03e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—MAPK1—coronary artery disease	1.21e-06	1.03e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.21e-06	1.03e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—IL6—coronary artery disease	1.21e-06	1.02e-05	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	1.21e-06	1.02e-05	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	1.21e-06	1.02e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CASP3—coronary artery disease	1.2e-06	1.01e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CASP3—coronary artery disease	1.19e-06	1.01e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—IL6—coronary artery disease	1.19e-06	1.01e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—IL6—coronary artery disease	1.19e-06	1e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—PIK3CA—coronary artery disease	1.19e-06	1e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CCND1—coronary artery disease	1.18e-06	1e-05	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	1.18e-06	1e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	1.18e-06	9.95e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	1.17e-06	9.91e-06	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	1.17e-06	9.89e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CCND1—coronary artery disease	1.16e-06	9.86e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	1.16e-06	9.85e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CCND1—coronary artery disease	1.16e-06	9.83e-06	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PPARG—coronary artery disease	1.16e-06	9.83e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.15e-06	9.76e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—AGT—coronary artery disease	1.15e-06	9.76e-06	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MMP9—coronary artery disease	1.15e-06	9.72e-06	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—POMC—coronary artery disease	1.15e-06	9.7e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.14e-06	9.67e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	1.14e-06	9.65e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.14e-06	9.63e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	1.14e-06	9.62e-06	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	1.14e-06	9.62e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MMP9—coronary artery disease	1.13e-06	9.57e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—APOE—coronary artery disease	1.13e-06	9.56e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MMP9—coronary artery disease	1.13e-06	9.55e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CAT—coronary artery disease	1.12e-06	9.5e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—APOA1—coronary artery disease	1.12e-06	9.45e-06	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—AKT1—coronary artery disease	1.11e-06	9.43e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	1.11e-06	9.37e-06	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	1.1e-06	9.3e-06	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IL6—coronary artery disease	1.1e-06	9.29e-06	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IL6—coronary artery disease	1.1e-06	9.28e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	1.1e-06	9.28e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—AKT1—coronary artery disease	1.09e-06	9.26e-06	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—PIK3CA—coronary artery disease	1.09e-06	9.26e-06	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IL6—coronary artery disease	1.09e-06	9.22e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—APOB—coronary artery disease	1.09e-06	9.22e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	1.09e-06	9.21e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	1.08e-06	9.15e-06	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	1.08e-06	9.13e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	1.07e-06	9.09e-06	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	1.07e-06	9.08e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.07e-06	9.05e-06	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—PIK3CA—coronary artery disease	1.07e-06	9.03e-06	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—PIK3CA—coronary artery disease	1.06e-06	8.99e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.06e-06	8.97e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	1.06e-06	8.97e-06	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	1.06e-06	8.95e-06	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—PIK3CA—coronary artery disease	1.05e-06	8.91e-06	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	1.05e-06	8.91e-06	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IL6—coronary artery disease	1.05e-06	8.89e-06	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—ALB—coronary artery disease	1.04e-06	8.84e-06	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	1.04e-06	8.83e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—LPL—coronary artery disease	1.04e-06	8.8e-06	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—VEGFA—coronary artery disease	1.03e-06	8.73e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	1.03e-06	8.71e-06	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	1.02e-06	8.66e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	1.02e-06	8.59e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GPX1—coronary artery disease	1.02e-06	8.59e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—VEGFA—coronary artery disease	1.01e-06	8.57e-06	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—AKT1—coronary artery disease	1.01e-06	8.57e-06	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—AKT1—coronary artery disease	1.01e-06	8.56e-06	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—AKT1—coronary artery disease	1.01e-06	8.51e-06	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—NOS3—coronary artery disease	9.99e-07	8.46e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	9.98e-07	8.44e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	9.94e-07	8.41e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CD36—coronary artery disease	9.89e-07	8.36e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PPARG—coronary artery disease	9.84e-07	8.33e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PPP2CA—coronary artery disease	9.76e-07	8.26e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—POMC—coronary artery disease	9.71e-07	8.21e-06	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—AKT1—coronary artery disease	9.69e-07	8.2e-06	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TGFB1—coronary artery disease	9.47e-07	8.02e-06	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IL6—coronary artery disease	9.45e-07	8e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—MTHFR—coronary artery disease	9.37e-07	7.93e-06	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IL6—coronary artery disease	9.33e-07	7.89e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	9.32e-07	7.89e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TGFB1—coronary artery disease	9.3e-07	7.87e-06	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MAPK1—coronary artery disease	9.29e-07	7.86e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	9.24e-07	7.82e-06	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	9.18e-07	7.77e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	9.14e-07	7.73e-06	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PTGS2—coronary artery disease	9.14e-07	7.73e-06	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	9.13e-07	7.73e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	9.13e-07	7.72e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MAPK1—coronary artery disease	9.12e-07	7.72e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	8.95e-07	7.57e-06	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—AKT1—coronary artery disease	8.94e-07	7.56e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—AGT—coronary artery disease	8.9e-07	7.53e-06	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	8.88e-07	7.52e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ALB—coronary artery disease	8.85e-07	7.49e-06	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—AKT1—coronary artery disease	8.72e-07	7.38e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—APOE—coronary artery disease	8.72e-07	7.38e-06	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—AKT1—coronary artery disease	8.68e-07	7.34e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—PIK3CA—coronary artery disease	8.63e-07	7.3e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—APOA1—coronary artery disease	8.62e-07	7.29e-06	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—AKT1—coronary artery disease	8.61e-07	7.28e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	8.48e-07	7.17e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—NOS3—coronary artery disease	8.47e-07	7.16e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	8.32e-07	7.04e-06	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IL6—coronary artery disease	8.13e-07	6.88e-06	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IL6—coronary artery disease	8.09e-07	6.84e-06	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	8.06e-07	6.82e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	7.93e-07	6.71e-06	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—PIK3CA—coronary artery disease	7.92e-07	6.71e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	7.91e-07	6.7e-06	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—PIK3CA—coronary artery disease	7.91e-07	6.69e-06	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IL6—coronary artery disease	7.87e-07	6.66e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	7.77e-07	6.57e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PTGS2—coronary artery disease	7.74e-07	6.55e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PPARG—coronary artery disease	7.6e-07	6.43e-06	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—AKT1—coronary artery disease	7.5e-07	6.35e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—POMC—coronary artery disease	7.49e-07	6.34e-06	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—AKT1—coronary artery disease	7.46e-07	6.31e-06	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	7.26e-07	6.14e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	7.22e-07	6.11e-06	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL6—coronary artery disease	7.14e-07	6.04e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—AKT1—coronary artery disease	7.05e-07	5.97e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL6—coronary artery disease	7.02e-07	5.94e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL6—coronary artery disease	7.01e-07	5.93e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL6—coronary artery disease	6.88e-07	5.82e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ALB—coronary artery disease	6.83e-07	5.78e-06	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—AKT1—coronary artery disease	6.59e-07	5.57e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—NOS3—coronary artery disease	6.53e-07	5.53e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—AKT1—coronary artery disease	6.48e-07	5.48e-06	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—AKT1—coronary artery disease	6.47e-07	5.48e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—AKT1—coronary artery disease	6.47e-07	5.47e-06	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—AKT1—coronary artery disease	6.46e-07	5.47e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL6—coronary artery disease	6.39e-07	5.41e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	6.34e-07	5.37e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PTGS2—coronary artery disease	5.98e-07	5.06e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	5.89e-07	4.99e-06	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PIK3CA—coronary artery disease	5.62e-07	4.76e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PIK3CA—coronary artery disease	4.76e-07	4.03e-06	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—AKT1—coronary artery disease	4.59e-07	3.89e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—AKT1—coronary artery disease	3.89e-07	3.29e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PIK3CA—coronary artery disease	3.68e-07	3.11e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—AKT1—coronary artery disease	3e-07	2.54e-06	CbGpPWpGaD
